🇺🇸 FDA
Patent

US 6090795

Human derived monocyte attracting purified peptide products useful in a method of treating infection and neoplasms in a human body

expired A61KA61K38/00

Quick answer

US patent 6090795 (Human derived monocyte attracting purified peptide products useful in a method of treating infection and neoplasms in a human body) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/00